Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Schoepp

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Neuropharmacology|February 13, 2001
(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cordN K Thomas, R A Wright, P A Howson, et al.
Journal of Neuroscience Methods|June 1, 1995
Second-messenger responses in brain slices to elucidate novel glutamate receptorsD D Schoepp, B G Johnson, C R Salhoff, et al.
Journal of Medicinal Chemistry|February 17, 1998
2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitutionP L Ornstein, T J Bleisch, M B Arnold, et al.
European Journal of Pharmacology|January 27, 1988
Endothelium-dependent modulation of angiotensin II-induced contraction in blood vesselsC A Gruetter, E T Ryan, S M Lemke, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
[3H]LY341495, a highly potent, selective and novel radioligand for labeling Group II metabotropic glutamate receptorsP L Ornstein, M B Arnold, T J Bleisch, et al.
Neuropharmacology|October 26, 1999
[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cellsB G Johnson, R A Wright, M B Arnold, et al.
CNS Spectrums|December 2, 2004
Glutamate-hypothalamic-pituitary-adrenal axis interactions: implications for mood and anxiety disordersS J Mathew, J D Coplan, D D Schoepp, et al.
Neuroscience Letters|November 12, 1993
Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonistsJ P Tizzano, K I Griffey, J A Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1990
Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of actionD D Schoepp, P L Ornstein, J D Leander, et al.
Journal of Medicinal Chemistry|January 1, 1991
4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of actionP L Ornstein, D D Schoepp, M B Arnold, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Neuropharmacology|February 13, 2001
(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cordN K Thomas, R A Wright, P A Howson, et al.
Journal of Neuroscience Methods|June 1, 1995
Second-messenger responses in brain slices to elucidate novel glutamate receptorsD D Schoepp, B G Johnson, C R Salhoff, et al.
Journal of Medicinal Chemistry|February 17, 1998
2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitutionP L Ornstein, T J Bleisch, M B Arnold, et al.
European Journal of Pharmacology|January 27, 1988
Endothelium-dependent modulation of angiotensin II-induced contraction in blood vesselsC A Gruetter, E T Ryan, S M Lemke, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
[3H]LY341495, a highly potent, selective and novel radioligand for labeling Group II metabotropic glutamate receptorsP L Ornstein, M B Arnold, T J Bleisch, et al.
Neuropharmacology|October 26, 1999
[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cellsB G Johnson, R A Wright, M B Arnold, et al.
CNS Spectrums|December 2, 2004
Glutamate-hypothalamic-pituitary-adrenal axis interactions: implications for mood and anxiety disordersS J Mathew, J D Coplan, D D Schoepp, et al.
Neuroscience Letters|November 12, 1993
Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonistsJ P Tizzano, K I Griffey, J A Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1990
Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of actionD D Schoepp, P L Ornstein, J D Leander, et al.
Journal of Medicinal Chemistry|January 1, 1991
4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of actionP L Ornstein, D D Schoepp, M B Arnold, et al.
Pageof 13